SYRA HEALTH CORP - CLASS A (SYRA)

US87168W2035 - Common Stock

0.4901  +0.04 (+8.96%)

After market: 0.515 +0.02 (+5.08%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024
Revenue
YoY % growth
1.41M5.62M
298.58%		5.515M
-1.87%		8.148M
47.74%
EBITDA
YoY % growth
210-2.075M
-988,266.67%		-2.839M
-36.80%		N/A
EBIT
YoY % growth
-2.09M-2.888M
-38.16%		-3.99M
-38.19%
Operating Margin
N/A-37.19%-52.36%-48.97%
EPS
YoY % growth
N/AN/AN/A-0.54
-6.00%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24
EPS
Q2Q % growth		-0.07
55.38%
Revenue
Q2Q % growth		2.052M
16.19%
EBITDA
Q2Q % growth		N/A
EBIT
Q2Q % growth		-660.96K
32.98%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth		 -0.06 -0.210.1571.99%
Q2 2024
Q2Q % growth		 -0.21 -0.19-0.02-8.36%
Q1 2024
Q2Q % growth		 -0.22 -0.19-0.03-13.52%
Q4 2023
Q2Q % growth		 -0.16 -0.09-0.07-74.29%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth		 2.253M
42.47%		2.031M222K10.93%
Q2 2024
Q2Q % growth		 1.97M
100.99%		1.825M144.68K7.93%
Q1 2024
Q2Q % growth		 1.752M
47.26%		1.43M322.34K22.54%
Q4 2023
Q2Q % growth		 1.766M
-68.56%		2.273M-507K-22.31%
Q2 2023
Q2Q % growth		 980K
-17.65%		%
Q1 2023
Q2Q % growth		 1.19M
25.26%		%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 58.82% 0% 38.37%
Revenue0% -39.98% 0% 3.4%